BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Kidney
,
Amniocentesis
,
Clofibrate
,
rs6983267
,
DRD2
,
glucose metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
fragilis
Summary
General Info
Curated Studies
Most Correlated Studies
Colorectal cancer HT 29/C1 cells treated with Bacteroides fragilis toxin-2
Induced C2 M cells in the presence of commensal bacteria
Single cells study of primordial germ cell lineage
Primordial germ cell gene expression in developing mice
Explore Curated Studies Results
Literature
Most Relevant Literature
An upgraded version of carbapenem inactivation method to detect Bacteroides fragilis carbapenemase.
A systemic review of the role of enterotoxic Bacteroides fragilis in colorectal cancer.
A tale of two habitats: Bacteroides fragilis, a lethal pathogen and resident in the human gastrointe…
Haemin deprivation renders Bacteroides fragilis hypersusceptible to metronidazole and cancels high-l…
Gut microbiota accelerates obesity in peri-/post-menopausal women via Bacteroides fragilis and aceti…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of the Interactions Between Dientamoba Fragilis and the Gut Microbiota
Treatment Study of Metronidazole to Treat Dientamoebiasis in Children
A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intra…
Safety, Potential Efficacy, and Pharmacokinetics of PZ-601 in the Treatment of Complicated Skin and …
Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile Infection
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ